Brokerages Set Ralliant Corporation (NYSE:RAL) Target Price at $57.89

Shares of Ralliant Corporation (NYSE:RAL) have been given an average recommendation of “Moderate Buy” by the twelve analysts that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $58.00.

A number of analysts have weighed in on the stock. Royal Bank Of Canada boosted their target price on shares of Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a research note on Friday, November 7th. Citigroup upgraded Ralliant from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $53.00 to $61.00 in a research report on Monday, December 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Ralliant in a research report on Monday, December 29th. Truist Financial started coverage on Ralliant in a research note on Friday, December 12th. They set a “buy” rating and a $62.00 price target on the stock. Finally, Barclays upped their price objective on Ralliant from $59.00 to $60.00 and gave the company an “overweight” rating in a research note on Wednesday.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. ST Germain D J Co. Inc. bought a new stake in shares of Ralliant in the 2nd quarter valued at about $27,000. Manchester Capital Management LLC bought a new stake in Ralliant in the second quarter valued at approximately $29,000. Westfuller Advisors LLC acquired a new stake in Ralliant during the 3rd quarter valued at approximately $26,000. Palisade Asset Management LLC bought a new position in Ralliant during the 3rd quarter worth approximately $26,000. Finally, UMB Bank n.a. acquired a new position in shares of Ralliant in the 3rd quarter worth approximately $29,000.

Ralliant Stock Up 2.5%

NYSE:RAL opened at $52.48 on Tuesday. Ralliant has a twelve month low of $40.70 and a twelve month high of $55.08. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. The company has a 50-day simple moving average of $49.32. The firm has a market capitalization of $5.92 billion and a price-to-earnings ratio of 41.33.

Ralliant (NYSE:RAL) last posted its earnings results on Wednesday, November 5th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to the consensus estimate of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Monday, December 8th were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, December 8th. Ralliant’s payout ratio is 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.